BSX
Boston Scientific Corporation
Stock
$42.60−0.63 (−1.46%)Close Oct 2, 2026
- Operating income, 2025
- $3.6B
- YoY, 2025
- +38.8%
Operating income
Operating income by fiscal year
| Period | Operating income | YoY |
|---|---|---|
| 2025 | $3.6B | +38.8% |
| 2024 | $2.6B | +11.1% |
| 2023 | $2.3B | +42.1% |
| 2022 | $1.6B | +37.5% |
| 2021 | $1.2B | — |
| 2020 | −$80M | — |
| 2019 | $1.5B | +0.8% |
| 2018 | $1.5B | +17.2% |
| 2017 | $1.3B | +187.5% |
| 2016 | $447M | — |
| 2015 | −$283M | — |
| 2014 | −$301M | — |
| 2013 | $120M | — |
| 2012 | −$3.9B | — |
| 2011 | $904M | — |
| 2010 | −$656M | — |
| 2009 | −$894M | — |
| 2008 | −$1.5B | — |
| 2007 | −$14M | — |